Cited 0 time in
Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults (vol 40, pg 754, 2018)
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lin, S. | - |
| dc.contributor.author | Nikanjam, M. | - |
| dc.contributor.author | Capparelli, E., V | - |
| dc.contributor.author | Kang, Ju-Seop | - |
| dc.date.accessioned | 2022-07-10T01:03:43Z | - |
| dc.date.available | 2022-07-10T01:03:43Z | - |
| dc.date.created | 2021-05-11 | - |
| dc.date.issued | 2019-04 | - |
| dc.identifier.issn | 0163-4356 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/148101 | - |
| dc.description.abstract | In the December 2018 issue of Therapeutic Drug Monitoring in the article "Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults" by Lin et al., an additional author, Ju-Seop Kang, MD, PhD, of the Department of Pharmacology & Clinical Pharmacology Lab, College of Medicine, Hanyang University, Seoul, Republic of Korea, should have been listed among the authors of the article, but was omitted at publication. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
| dc.title | Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults (vol 40, pg 754, 2018) | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Kang, Ju-Seop | - |
| dc.identifier.doi | 10.1097/FTD.0000000000000624 | - |
| dc.identifier.scopusid | 2-s2.0-85063284429 | - |
| dc.identifier.wosid | 000480709000022 | - |
| dc.identifier.bibliographicCitation | THERAPEUTIC DRUG MONITORING, v.41, no.2, pp.256 - 256 | - |
| dc.relation.isPartOf | THERAPEUTIC DRUG MONITORING | - |
| dc.citation.title | THERAPEUTIC DRUG MONITORING | - |
| dc.citation.volume | 41 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 256 | - |
| dc.citation.endPage | 256 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Correction | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Medical Laboratory Technology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Toxicology | - |
| dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Toxicology | - |
| dc.identifier.url | https://journals.lww.com/drug-monitoring/Fulltext/2019/04000/Evaluation_of_Omeprazole_Limited_Sampling.22.aspx | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
